OSTX

OS Therapies
OSTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$51.70M
EV
$53.53M
Shares Outstanding
28.10M
Beta
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$13.50
P/E 2025E
2.43x
P/Revenue 2025E
1.88x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About OS Therapies Incorporated

gainify
OSTX

OS Therapies Incorporated

OSTX

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immuno...

Sector

Healthcare

Industry

Biotechnology

CEO

Romness, Paul

Employees

5

IPO Date

2024-08-01

Headquarters

15825 Shady Grove Road, Suite 135, Rockville, Maryland, 20850, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.